Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 106 results for "zydus group cadila healthcare"

Zydus gets tentative nod from USFDA to market diabetic tablets
India TV

Zydus gets USFDA nod to market anti-diabetic tablets; closes d...

Cadila Healthcare closed today at 1.15% at Rs. 1,272 on BSE. The stock opened at Rs. 1,300 and closed at Rs. 1,272. The stock hit a high of Rs. 1323 and a low of Rs. 1,262. Zydus Cadila has received tentative approval from the USFDA to market ... India Infoline, 1 month ago
Zydus gets USFDA tentative nod for diabetic tablets Press Trust of India, 1 month ago
[x]  

Buy Cadila Healthcare; tgt of Rs 1410: Firstcall Research

Firstcall Research report on Cadila Healthcare Zydus Cadila, a global healthcare provider was founded by Late Mr. Ramanbhai B. Patel in 1952. In 1995, the group restructured its operations and emerged with a new identity under the aegis of Zydus ...
 Moneycontrol.com3 weeks ago Cadila Healthcare jumps after USFDA OK for anti-viral drug  Capital Market2 months ago

Zydus gets Gilead licence for Hepatitis C treatment

Cadila Healthcare Ltd (Zydus Cadila) on Monday said it has been granted generic licence by Gilead Sciences Inc, to manufacture breakthrough treatment of Hepatitis C. The two companies have entered into a generic, non-exclusive licensing agreement ...
 Hindu Business Line1 month ago Zydus and Gilead Enter into a Generic Licensing Agreement to manufacture breakthrough treatment for Hepatitis C  Equity Bulls1 month ago Zydus granted license to produce generic hepatitis C drug  Smart Investor1 month ago

India : TENTATIVE Approval for Glipizide ER Tablets received by Zydus [TendersInfo (India)]

Cadila Healthcare Ltd. said that it had obtained tentative approval from the US FDA o market Glipizide Extended-release tablets in the strengths of 2.5 mg, 5 mg and 10 mg. The drug falls in the anti-diabetic segment. As per IMS data the estimates ...
 Pharmacy Choice1 month ago Zydus Cadila gets tentative approval from US FDA for Glipizide ER tablets  Indian-Commodity1 month ago
Business Standard India

Zydus Cadila bags license for hepatitis C drug

medabad-based pharma major Cadila Healthcare (Zydus Cadila) today announced that it has signed a non-exclusive licensing agreement with Gilead Sciences Inc, which will allow the generic manufacture of sofosbuvir and ledipasvir (used for treatment of ...
 Business Standard India1 month ago CADILA HEALTHCARE : Zydus Cadila Q1 Net profit up by 23%  4 Traders2 months ago
Financial Express

Cadila Healthcare recalls anti-hypertension drug in US

Drug firm Cadila Healthcare is voluntarily recalling 5,400 bottles of anti-hypertension drug Atenolol tablets, in the U.S. for failing to meet specifications. According to a notification by the US Food and Drug Administration (USFDA), the recall ...
 Hindu Business Line4 days ago Cadila Healthcare recalls blood pressure drug in the US  Business Standard India5 days ago
[x]  

Stock Prices as on Oct 16, 2014

GROUP A A A B B 1013.55(1055.7) 1263-540 (7) A C C 1377.85(1383.5) 1570-971 (17) Abbot 3034.9(3058.4) 3462-1305 (1) Abg Shipyard 222.3(233.55) 327-210 (31) Abirlanuv 1593.0(1636.0) 1738-1030 (8) Acl 205.35(208.55) 243-150 (70) Adani Enter 444.2(452.95) ...
 Deccan Herald5 days ago

Stocks in news: Maruti, JSPL, Wockhardt, Bharti, Cadila

Q1FY15 GDP at 5.7 percent versus 4.7 percent (YoY) -Q1FY15 GDP at 5.7 percent versus 4.6 percent (QoQ) Alert: Q1FY15 GDP at 5.7 percent, highest since Q4FY12 -Agri sector growth at 3.8 percent versus 4 percent (YoY)-Agri sector growth at 3.8 ...
 Moneycontrol.com1 month ago
Animal Pharm News

India's leading animal health companies: Good past, great future

While animal health is a key growth market in India, little is known about who will be capitalizing on this opportunity? Industry expert Dr Sandeep Juneja sheds some light on the domestic and international players in Indian animal health. Large ...
 Animal Pharm News1 week ago

Osteoporosis & Osteoarthritis Therapeutic Pipeline Review (Company & Drugs Profile) H2 2014 in a New Report Available at RnRMarketResearch.com

This report provides comprehensive information on the therapeutic development for Osteoarthritis & Osteoporosis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of ...
 Digital Journal4 days ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - zydus group cadila healthcare
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less